598 related articles for article (PubMed ID: 27903744)
1. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.
Wu H; Kong L; Cheng Y; Zhang Z; Wang Y; Luo M; Tan Y; Chen X; Miao L; Cai L
Free Radic Biol Med; 2015 Dec; 89():431-42. PubMed ID: 26415026
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice.
Zhou S; Wang J; Yin X; Xin Y; Zhang Z; Cui T; Cai J; Zheng Y; Liu Q; Cai L
Redox Biol; 2018 Oct; 19():11-21. PubMed ID: 30096613
[TBL] [Abstract][Full Text] [Related]
5. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
Bai Y; Cui W; Xin Y; Miao X; Barati MT; Zhang C; Chen Q; Tan Y; Cui T; Zheng Y; Cai L
J Mol Cell Cardiol; 2013 Apr; 57():82-95. PubMed ID: 23353773
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.
Zhang Z; Wang S; Zhou S; Yan X; Wang Y; Chen J; Mellen N; Kong M; Gu J; Tan Y; Zheng Y; Cai L
J Mol Cell Cardiol; 2014 Dec; 77():42-52. PubMed ID: 25268649
[TBL] [Abstract][Full Text] [Related]
7. Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice.
Wang J; Wang S; Wang W; Chen J; Zhang Z; Zheng Q; Liu Q; Cai L
J Cell Mol Med; 2019 Sep; 23(9):6319-6330. PubMed ID: 31270951
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway.
Xin Y; Bai Y; Jiang X; Zhou S; Wang Y; Wintergerst KA; Cui T; Ji H; Tan Y; Cai L
Redox Biol; 2018 May; 15():405-417. PubMed ID: 29353218
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
10. Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation.
Cui W; Bai Y; Miao X; Luo P; Chen Q; Tan Y; Rane MJ; Miao L; Cai L
Oxid Med Cell Longev; 2012; 2012():821936. PubMed ID: 23050040
[TBL] [Abstract][Full Text] [Related]
11. Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.
Jiang X; Bai Y; Zhang Z; Xin Y; Cai L
Toxicol Appl Pharmacol; 2014 Sep; 279(2):198-210. PubMed ID: 24967692
[TBL] [Abstract][Full Text] [Related]
12. Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice.
Xu Z; Wang S; Ji H; Zhang Z; Chen J; Tan Y; Wintergerst K; Zheng Y; Sun J; Cai L
Sci Rep; 2016 Jul; 6():30252. PubMed ID: 27457280
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function.
Wang Y; Zhang Z; Guo W; Sun W; Miao X; Wu H; Cong X; Wintergerst KA; Kong X; Cai L
Am J Physiol Endocrinol Metab; 2014 Jul; 307(1):E14-23. PubMed ID: 24801392
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
Wang Y; Zhou S; Sun W; McClung K; Pan Y; Liang G; Tan Y; Zhao Y; Liu Q; Sun J; Cai L
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1239-47. PubMed ID: 24714399
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity.
Pu D; Zhao Y; Chen J; Sun Y; Lv A; Zhu S; Luo C; Zhao K; Xiao Q
Neuroscience; 2018 Jun; 381():35-45. PubMed ID: 29684505
[TBL] [Abstract][Full Text] [Related]
16. Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein.
Zhou S; Yin X; Jin J; Tan Y; Conklin DJ; Xin Y; Zhang Z; Sun W; Cui T; Cai J; Zheng Y; Cai L
Free Radic Biol Med; 2017 Nov; 112():224-239. PubMed ID: 28778483
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of Nrf2 expression and function.
Wang Y; Zhang Z; Sun W; Tan Y; Liu Y; Zheng Y; Liu Q; Cai L; Sun J
Oxid Med Cell Longev; 2014; 2014():123963. PubMed ID: 24707343
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
19. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
